VASO Corp (VASO) stock
VASOOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
$0.29+0.00 (+0.06%)
Close on Oct 19, 2026Market cap $51.17MP/E 29.0Yield –
VASO r&d expenses
Research and development expenses are spending on new products and technology.
VASO's R&D Expenses for the twelve months ending Jun 30, 2026 was $778.00K, down 2.7% year over year. For fiscal 2025 it was $728.00K, down 14.5% from the year before. Over ten years it grew 3.5% a year on average. The highest annual figure on record is $1.72M in fiscal 2021.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $728.00K | -14.5% |
| FY2024 | Dec 31, 2024 | $851.00K | +12.7% |
| FY2023 | Dec 31, 2023 | $755.00K | +24.8% |
| FY2022 | Dec 31, 2022 | $605.00K | -64.8% |
| FY2021 | Dec 31, 2021 | $1.72M | +131.0% |
| FY2020 | Dec 31, 2020 | $745.00K | -8.4% |
| FY2019 | Dec 31, 2019 | $813.00K | -8.2% |
| FY2018 | Dec 31, 2018 | $886.00K | -6.2% |
| FY2017 | Dec 31, 2017 | $945.00K | +78.3% |
| FY2016 | Dec 31, 2016 | $530.00K | +2.9% |
| FY2015 | Dec 31, 2015 | $515.00K | -35.9% |
| FY2014 | Dec 31, 2014 | $803.00K | +16.5% |
| FY2013 | Dec 31, 2013 | $689.00K | +49.1% |
| FY2011 | May 31, 2011 | $462.00K | +10.3% |
| FY2010 | May 31, 2010 | $419.00K | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $212.00K | +26.9% |
| Q1 FY2026 | Mar 31, 2026 | $183.00K | +2.8% |
| Q4 FY2025 | Dec 31, 2025 | $237.00K | -10.2% |
| Q3 FY2025 | Sep 30, 2025 | $146.00K | -23.6% |
| Q2 FY2025 | Jun 30, 2025 | $167.00K | -18.5% |
| Q1 FY2025 | Mar 31, 2025 | $178.00K | -6.8% |
| Q4 FY2024 | Dec 31, 2024 | $264.00K | +54.4% |
| Q3 FY2024 | Sep 30, 2024 | $191.00K | -8.6% |
| Q2 FY2024 | Jun 30, 2024 | $205.00K | -5.5% |
| Q1 FY2024 | Mar 31, 2024 | $191.00K | +21.7% |
| Q4 FY2023 | Dec 31, 2023 | $171.00K | -6.6% |
| Q3 FY2023 | Sep 30, 2023 | $209.00K | +60.8% |
| Q2 FY2023 | Jun 30, 2023 | $217.00K | +27.6% |
| Q1 FY2023 | Mar 31, 2023 | $157.00K | +28.7% |
| Q4 FY2022 | Dec 31, 2022 | $183.00K | -85.7% |
| Q3 FY2022 | Sep 30, 2022 | $130.00K | +5.7% |
| Q2 FY2022 | Jun 30, 2022 | $170.00K | 0.0% |
| Q1 FY2022 | Mar 31, 2022 | $122.00K | -15.3% |
| Q4 FY2021 | Dec 31, 2021 | $1.28M | +523.3% |
| Q3 FY2021 | Sep 30, 2021 | $123.00K | -29.3% |
| Q2 FY2021 | Jun 30, 2021 | $170.00K | -7.1% |
| Q1 FY2021 | Mar 31, 2021 | $144.00K | -20.0% |
| Q4 FY2020 | Dec 31, 2020 | $206.00K | +9.0% |
| Q3 FY2020 | Sep 30, 2020 | $174.00K | -11.2% |
| Q2 FY2020 | Jun 30, 2020 | $183.00K | -19.7% |
| Q1 FY2020 | Mar 31, 2020 | $180.00K | -10.0% |
| Q4 FY2019 | Dec 31, 2019 | $189.00K | -13.3% |
| Q3 FY2019 | Sep 30, 2019 | $196.00K | -14.8% |
| Q2 FY2019 | Jun 30, 2019 | $228.00K | -9.5% |
| Q1 FY2019 | Mar 31, 2019 | $200.00K | +7.0% |
| Q4 FY2018 | Dec 31, 2018 | $218.00K | -4.8% |
| Q3 FY2018 | Sep 30, 2018 | $230.00K | -2.1% |
| Q2 FY2018 | Jun 30, 2018 | $252.00K | -3.1% |
| Q1 FY2018 | Mar 31, 2018 | $187.00K | -15.4% |
| Q4 FY2017 | Dec 31, 2017 | $229.00K | +42.2% |
| Q3 FY2017 | Sep 30, 2017 | $235.00K | +100.9% |
| Q2 FY2017 | Jun 30, 2017 | $260.00K | – |
| Q1 FY2017 | Mar 31, 2017 | $221.00K | – |
| Q4 FY2016 | Dec 31, 2016 | $161.00K | – |
| Q3 FY2016 | Sep 30, 2016 | $117.00K | – |
See a number that looks wrong?